Bavarian Nordic AS (OCSE:BAVA) is set to release its Q3 2024 earnings on Nov 15, 2024. The consensus estimate for Q3 2024 ...

Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, ...

The vaccines the DRC currently has are manufactured by Danish drugmaker Bavarian Nordic and only intended for adults. The DRC ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

The World Health Organisation declared mpox a global health emergency in mid-August, after a new strain began spreading from ...

Russia has claimed that there is an increased interest from African and ex-Soviet countries in its mpox vaccine, Orthopoxvac ...

A spokesperson for Bavarian Nordic said 265,000 doses of its mpox vaccine, Jynneos, had been delivered to African countries, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

An independent study has found that Bavarian Nordic's mpox vaccine Jynneos – currently only authorised for use in adults in the US – is also safe and generates a strong antibody response in ...